Drug-drug interactions that occur at the level of drug transporters can have unexpected and severe side effects. The hepatic drug transporters of the organic anion transporting polypeptide (OATP) superfamily transport numerous endo- and xenobiotics (drugs) and are therefore important for drug disposition. The two liver specific OATP1B1 and OATP1B3 have broad and overlapping substrate specificity, but also transport distinct and unique substrates. However, there is nothing known about how OATPs recognize and transport different compounds. So far it is impossible to make exact predictions on whether a compound will be a substrate or not, and whether a possible drug-interaction might occur. Because OATPs are potential sites of drug-drug interactions that can lead to severe adverse effects, these unknowns should be clarified. Therefore, the long-term goal of the proposed studies is to understand, predict and prevent OATP related drug-drug interactions. The objective of this particular application is to determine the molecular basis of the polyspecificity of the liver-specific transporters, OATP1B1 and OATP1B3. The central hypothesis for the proposed research is that different substrates are transported by OATP1B1 and OATP1B3 using multiple transport/binding sites. Malfunction of these transporters (inhibition, up- or down-regulation, and polymorphisms) will affect drug bioavailability and can lead to adverse drug actions. We plan to test our central hypothesis and accomplish the overall objective of this application with the following four specific aims: 1) Characterize the substrate specificity of OATP1B1 and OATP1B3 with emphasis on nuclear receptor ligands;2) Perform a detailed 3D-QSAR analysis for OATP1B1 and OATP1B3;3) Determine the membrane topology;and 4) Identify the substrate binding sites of OATP1B1 and OATP1B3 using chimeras and site directed mutagenesis. A detailed understanding on how the liver specific drug transporters OATP1B1 and OATP1B3 recognize and transport their different substrates will help to predict and prevent adverse drug-drug interactions and to develop new therapeutic compounds to target the liver. Once this knowledge is available, there is the promise that it will be possible to develop safer medication which will result in less hospitalizations.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM077336-04
Application #
7793361
Study Section
Xenobiotic and Nutrient Disposition and Action Study Section (XNDA)
Program Officer
Okita, Richard T
Project Start
2007-04-01
Project End
2011-03-31
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
4
Fiscal Year
2010
Total Cost
$285,625
Indirect Cost
Name
University of Kansas
Department
Pharmacology
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Zhao, Wen; Zitzow, Jeremiah D; Weaver, Yi et al. (2017) Organic Anion Transporting Polypeptides Contribute to the Disposition of Perfluoroalkyl Acids in Humans and Rats. Toxicol Sci 156:84-95
Kreznar, Julia H; Keller, Mark P; Traeger, Lindsay L et al. (2017) Host Genotype and Gut Microbiome Modulate Insulin Secretion and Diet-Induced Metabolic Phenotypes. Cell Rep 18:1739-1750
Steiner, Konstanze; Zimmermann, Lisa; Hagenbuch, Bruno et al. (2016) Zebrafish Oatp-mediated transport of microcystin congeners. Arch Toxicol 90:1129-39
Li, Yuan; McGreal, Steven; Zhao, Jean et al. (2016) A cell-based quantitative high-throughput image screening identified novel autophagy modulators. Pharmacol Res 110:35-49
Stieger, Bruno; Hagenbuch, Bruno (2016) Recent advances in understanding hepatic drug transport. F1000Res 5:2465
Patik, Izabel; Kovacsics, Daniella; NĂ©met, Orsolya et al. (2015) Functional expression of the 11 human Organic Anion Transporting Polypeptides in insect cells reveals that sodium fluorescein is a general OATP substrate. Biochem Pharmacol 98:649-58
Zhao, Wen; Zitzow, Jeremiah D; Ehresman, David J et al. (2015) Na+/Taurocholate Cotransporting Polypeptide and Apical Sodium-Dependent Bile Acid Transporter Are Involved in the Disposition of Perfluoroalkyl Sulfonates in Humans and Rats. Toxicol Sci 146:363-73
Tian, Jianan; Keller, Mark P; Oler, Angie T et al. (2015) Identification of the Bile Acid Transporter Slco1a6 as a Candidate Gene That Broadly Affects Gene Expression in Mouse Pancreatic Islets. Genetics 201:1253-62
Woolbright, Benjamin L; Dorko, Kenneth; Antoine, Daniel J et al. (2015) Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis. Toxicol Appl Pharmacol 283:168-77
Nieuweboer, Annemieke J M; Hu, Shuiying; Gui, Chunshan et al. (2014) Influence of drug formulation on OATP1B-mediated transport of paclitaxel. Cancer Res 74:3137-45

Showing the most recent 10 out of 34 publications